These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6073927)

  • 1. The effect of medroxyprogesterone acetate on endometriosis in the human female.
    Gunning JE; Moyer D
    Fertil Steril; 1967; 18(6):759-74. PubMed ID: 6073927
    [No Abstract]   [Full Text] [Related]  

  • 2. Injectable long-acting progestogen contraception: a neglected modality.
    Rosenfield AG
    Am J Obstet Gynecol; 1974 Oct; 120(4):537-48. PubMed ID: 4606673
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis.
    Luciano AA; Turksoy RN; Carleo J
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):323-7. PubMed ID: 2970029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate.
    Cedars MI; Lu JK; Meldrum DR; Judd HL
    Obstet Gynecol; 1990 Apr; 75(4):641-5. PubMed ID: 2138265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Return of menstruation and fertility in Thai women after contraceptive injections.
    McDaniel EB; Pardthaisong T
    J Biosoc Sci; 1971 Apr; 3(2):209-22. PubMed ID: 5562064
    [No Abstract]   [Full Text] [Related]  

  • 6. [Depot medroxyprogesterone acetate as contraceptive agent].
    Duarte-Contreras A
    Rev Colomb Obstet Ginecol; 1973; 24(1):13-9. PubMed ID: 4804874
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of endometriosis with oral medroxyprogesterone acetate.
    Moghissi KS; Boyce CR
    Obstet Gynecol; 1976 Mar; 47(3):265-7. PubMed ID: 1250555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone-resistant endometriosis following total abdominal hysterectomy and bilateral salpingo-oophorectomy: correlation with histology and steroid receptor content.
    Metzger DA; Lessey BA; Soper JT; McCarty KS; Haney AF
    Obstet Gynecol; 1991 Nov; 78(5 Pt 2):946-50. PubMed ID: 1833687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of medroxyprogesterone acetate employed as a long-term injectable contraceptive.
    Ringrose CA
    J Reprod Med; 1972 Feb; 8(2):75-9. PubMed ID: 4666624
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of bleeding patterns and resumption of fertility following discontinuation of a long acting injectable contraceptive.
    Gardner JM; Mishell DR
    Fertil Steril; 1970 Apr; 21(4):286-91. PubMed ID: 5508497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medroxyprogesterone acetate in the control of fertility].
    Rubio Lotvin B; Gonzalez R; Litwak O; Bielak S
    Prensa Med Mex; 1969; 34(5):192-6. PubMed ID: 5386327
    [No Abstract]   [Full Text] [Related]  

  • 12. Prolonged gynecologic and endocrine manifestations subsequent to administration of medroxyprogesterone acetate during pregnancy.
    Turner SJ; Mizock GB; Feldman GL
    Am J Obstet Gynecol; 1966 May; 95(2):222-7. PubMed ID: 5935707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progeston therapy for menstrually related aphthae.
    Ferguson MM; McKay Hart D; Lindsay R; Stephen KW
    Int J Oral Surg; 1978 Oct; 7(5):463-70. PubMed ID: 102602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Depot contraceptives. Evaluation of various therapeutic schemes. Experience of 8 years' use].
    Rubio Lotvin B
    Prensa Med Mex; 1973; 38(11):435-43. PubMed ID: 4794102
    [No Abstract]   [Full Text] [Related]  

  • 15. Interval of injections of intramuscular depot medroxyprogesterone acetate in the long-term treatment of endometriosis-associated pain: a randomized comparative trial.
    Cheewadhanaraks S; Peeyananjarassri K; Choksuchat C; Dhanaworavibul K; Choobun T; Bunyapipat S
    Gynecol Obstet Invest; 2009; 68(2):116-21. PubMed ID: 19556801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experience with Cyclo-Provera, a parenteral monthly contraceptive. Preliminary report].
    Rubio Lotvin B; Ruíz Moreno JA; Bolio Arista R; Gónzalez Ansorena R
    Prensa Med Mex; 1974; 39(1-2):48-50. PubMed ID: 4420202
    [No Abstract]   [Full Text] [Related]  

  • 17. Pseudopregnancy induced by estrogen-progestogen or progestogens alone in the treatment of endometriosis.
    Moghissi KS
    Prog Clin Biol Res; 1990; 323():221-32. PubMed ID: 2137617
    [No Abstract]   [Full Text] [Related]  

  • 18. Medroxyprogesterone acetate as a contraceptive.
    Hornemann B; Osler M
    Int J Fertil; 1972; 17(4):210-6. PubMed ID: 4362388
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of medroxyprogesterone acetate and ethinyl estradiol on varied problems associated with the menstrual cycle. A comparison of a combination to a sequential regimen.
    Miyamoto J
    Acta Obstet Gynaecol Jpn; 1970 Oct; 17(4):233-8. PubMed ID: 4249753
    [No Abstract]   [Full Text] [Related]  

  • 20. Injectable contraception (medroxyprogesterone acetate) in rural Bangladesh.
    Parveen L; Chowdhury AQ; Chowdhury Z
    Lancet; 1977 Nov; 2(8045):946-8. PubMed ID: 72288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.